PATENT CLAIM ANALYSIS

Application Number: 16047915
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "303000"]

Abstract:
Substituted-3H-imidazo[4,5-c]pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) and related compounds, which are useful as inhibitors of ENPP1; synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of using the compounds and compositions to treat disorders associated with dysfunction of the ENPP1.

Claim (Index 2):
The compound according to  claim 1 , wherein Z is \u2014N; X 1  is \u2014C\u2550O; X 2  is \u2014NH; R 1  is selected from the group consisting of halogen and \u2014CN; R 2  is selected from the group consisting of \u2014H and \u2014CH 3 ; R 3  is \u2014H; R 4  is \u2014H; R 5  is and R 6  is selected from the group consisting of \u2014OCH 3 , and OH, or an isomer or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.5122
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15314938', '13905410', '12334371', '13470122', '15875678']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7831643398067544
- 35 USC 102 Novelty (BERT): 0.4957428443899176
- Combined Prediction Score: 0.7544221902650707
- Mean Citation Score: 243.805358
- Max Citation Score: 246.33662
- Similarity Product: 184.26666965652228

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test